Revised. Amendments from Version 1
==================================

Per reviewers\' comments we added background information about the subject matter (monocyte immunobiology), as well as details regarding the dataset selection and curation process. Figures 2 and 3 were also updated. The table orientation was changed, and we have also updated the title of this article.

Introduction
============

Platforms such as microarrays and, more recently, next generation sequencing have been leveraged to generate molecular profiles at the scale of entire systems. The global perspective gained using such approaches is potentially transformative. Transcriptome profiling enabled for instance the characterization of molecular perturbations that occur in the context of a wide range disease processes ^[@ref-1]--\ [@ref-10]^. This in turn has provided opportunities for the discovery of biomarkers and for the development of novel therapeutic modalities ^[@ref-3],\ [@ref-11]--\ [@ref-13]^. More recently such systems-scale profiling of the blood transcriptome has also been used to monitor response to vaccines or therapeutic drugs ^[@ref-14]--\ [@ref-19]^. The democratization of these approaches has led to proliferation of data in public repositories: over 1.7 million individual transcriptome profiles from more than 65,000 studies have been deposited to date in the [NCBI Gene Expression Omnibus](http://www.ncbi.nlm.nih.gov/geo/) (GEO), a public repository of transcriptome profiles.

Taken together this vast body of "collective data" holds the promise of accelerating the pace of biomedical discovery by creating countless opportunities for identifying and filling critical knowledge gaps. Building tools that provide biomedical researchers with the ability to seamlessly interact with collections of datasets along with rich contextual information is essential in promoting insight and enabling knowledge discovery. To address this need we have developed an interactive data browsing and visualization web application, the Gene Expression Browser (GXB).

GXB was described in a recent publication and is available as open source software on GitHub ^[@ref-20]^. This tool constitutes a simple interface for the browsing and interactive visualization of large volumes of heterogeneous data. Users can easily customize data plots by adding multiple layers of information, modifying the order of samples, and generating links that capture these settings, which can be inserted in email communications or in publications. Accessing the tool via these links also provides access to rich contextual information that is essential for data interpretation. This includes access to gene information and relevant literature, study design information, detailed sample information as well as ancillary data ^[@ref-20]^.

In recent years, a large number of transcriptional studies have been conducted aiming at the characterization and functional classification of monocytes in health and disease. Monocytes are a population of immune cells found in the blood, bone marrow, and spleen. They constitute \~10% of the total circulating blood leukocytes in humans. They can remain in the blood circulation for up to 1--2 days, after which time, if they have not been recruited to a tissue, they die and are removed. They are considered the systemic reservoir of myeloid precursors for renewal of tissue macrophages and dendritic cells. Monocytes play a key role during immune response as professional phagocytes ^[@ref-21],\ [@ref-22]^, and producers of immune mediators ^[@ref-23],\ [@ref-24]^. Indeed, reports show that monocytes are recruited at the site of infections as innate effectors of the inflammatory response to microbes, killing pathogens via phagocytosis, production of reactive oxygen intermediate (ROIs) ^[@ref-25]^, reactive nitrogen intermediate (RNIs) ^[@ref-26],\ [@ref-27]^, myeloperoxidase (MPO) ^[@ref-28],\ [@ref-29]^, and producing inflammatory cytokines ^[@ref-30]^ that contribute to further amplifying the antimicrobial response ^[@ref-31]^.

Human monocytes are derived from hematopoietic stem cells in the bone marrow and are released into peripheral blood circulation upon maturation. They are divided into three major subsets based on the expression of the cell surface markers CD14 and CD16. The most prevalent subset in the blood circulation, accounting for 90% of all monocytes, are the classical monocytes that express high levels of CD14 but low levels of CD16 (CD14++CD16-). The remaining 10% is divided into two subsets: intermediate monocytes with high expression of CD14 and CD16 (CD14++CD16+ or CD14+CD16+) and non-classical monocytes that express low levels of CD14 but high levels of CD16 (CD14dimCD16++ or CD14-CD16++) ^[@ref-32]--\ [@ref-34]^. The factors that govern the migration of monocytes and roles that each subset plays during disease processes are not well understood. 1) In autoimmune diseases: Non-classical monocytes are regarded as crucial effectors in the pathogenesis of rheumatoid arthritis, ankylosing spondylitis ^[@ref-35]^, systemic lupus erythematosus (SLE) ^[@ref-36]^ and multiple sclerosis ^[@ref-37]^. This monocyte subset carries a distinct inflammatory signature in patients with SLE ^[@ref-36]^. Classical monocytes on the other hand have been shown to dominate the inflamed mucosa in Crohn's disease ^[@ref-38]^. Skewing of monocytes towards the intermediate subset has been observed in patients with autoimmune uveitis and linked to administration of glucocorticoid therapy ^[@ref-39]^. 2) In cardiovascular diseases: circulating monocytes play a pivotal role by releasing cocktails of cytokines, factor and proteases that are involved in vascular growth ^[@ref-40]^. Monocyte subsets show functional and phenotypic changes in cardiovascular diseases. The accumulation of classical monocytes is for instance a hallmark of progression of atherosclerosis ^[@ref-41]--\ [@ref-43]^. An association between intermediate monocytes and cardiovascular events has also been documented with this monocyte subset being proportionally elevated following myocardial infarction or atrial fibrillation ^[@ref-44],\ [@ref-45]^ or in at risk subjects ^[@ref-46]^. 3) In cancer: Intermediate monocytes are viewed as potential diagnostic indicators for colorectal cancer ^[@ref-47]^. Another study has shown that elevated abundance of intermediate monocytes is associated with survival of adult or childhood acute lymphoblastic leukemia ^[@ref-48]^. The changes of gene expression profiles in monocytes reveal high specificity for the tissue type and cancer histotype, and are induced in response to soluble factors released by the cancer cells in the primary or metastatic site ^[@ref-49]^. Moreover, monocytes, comprising the monocyte-myeloid-derived suppressor cells population, from patients with metastatic breast cancer resemble the reprogrammed immunosuppressive monocytes in patients with severe infections, both by their surface and functional phenotype but also by their gene expression profile ^[@ref-50]^. This signature of immunosuppression could therefore constitute a good biomarker for assessing disease progression. 4) In infections: monocytes are also key players in the immediate immune response to infectious agents as well as the subsequent development of the adaptive immune response ^[@ref-51]^. Given the importance of classical and intermediate monocytes in pathogenesis of infectious and other inflammatory disorders, delineation of their functional and phenotypic characteristics has been studied extensively. The response mounted by classical monocytes has emerged as being critical for the control of a wide range of infectious diseases, including infections caused by bacteria ^[@ref-52]--\ [@ref-57]^, parasites ^[@ref-58]^ and fungi ^[@ref-59]^. In contrast, intermediate monocytes have been associated with pathologic immune responses against bacteria ^[@ref-60],\ [@ref-61]^ and parasites ^[@ref-62]^. In the context of HIV infection; CD14 expression is reduced on classical monocytes in chronically HIV-1 infected adults on anti-retroviral therapy ^[@ref-63],\ [@ref-64]^. Moreover, loss of CCR2 expressing non-classical monocytes is associated with cognitive impairment in antiretroviral therapy-naïve infected subjects ^[@ref-65]^. Altogether these findings indicate that monocytes are more than circulating precursors and have different effector functions in response to various infections and during inflammation. Clearly furthering our understanding of the role of monocyte subsets in health and disease will require many more studies, also we hope that the dataset compendium that we are making available to the research community via this publication can help support these endeavors.

In this data note we are making available via GXB a curated compendium of 93 public datasets relevant to human monocyte immunobiology, representing a total of 4,516 transcriptome profiles.

Materials and methods
=====================

Identification of monocyte datasets
-----------------------------------

Potentially relevant datasets deposited in GEO were identified using an advanced query based on the Bioconductor package GEOmetadb and the SQLite database that captures detailed information on the GEO data structure; <https://www.bioconductor.org/packages/release/bioc/html/GEOmetadb.html> ^[@ref-66]^. The search query was designed to retrieve entries where the title and description contained the word Monocyte OR Monocytes, were generated from human samples, using Illumina or Affymetrix commercial platforms. The query result is appended with rich metadata from GEOmetadb that allows for manual filtering of the retrieved collection.

The relevance of each entry returned by this query was assessed individually. This process involved reading through the descriptions and examining the list of available samples and their annotations. Sometimes it was also necessary to review the original published report in which the design of the study and generation of the dataset is described in more detail. Using the search query, the results also returned a number of datasets that did not include profiles of monocytes but instead of "monocyte-derived dendritic cells" or "monocyte-derived macrophages". During our manual screen these were excluded as were studies employing monocytic cell lines. Only studies including primary human monocyte profiles were retained. The datasets cover a broad range of studies investigating human monocyte immunobiology in the context of diseases and through comparison with diverse cell populations and study types as illustrated by a graphical representation of relative occurrences of terms in the descriptions of the studies loaded into our tool ( [Figure 1](#f1){ref-type="fig"}). A wide range of cell types and diseases are represented. Ultimately, the collection was comprised of 93 curated datasets. It includes datasets generated from studies profiling primary human CD14+ cells isolated from patients with autoimmune diseases (7), bacterial, virus and parasite infections (7), cancer (4), cardiovascular diseases (4), kidney diseases (4), as well as monocytes isolated from healthy subjects (58) ( [Figure 2](#f2){ref-type="fig"}). The 58 datasets in which monocytes were isolated from healthy subjects were classified based on whether profiling was conducted *ex vivo* or following *in vitro* experiments. In total 38 datasets were identified in which primary human CD14+ cells were stimulated or infected in *in vitro* experiments ( [Figure 2](#f2){ref-type="fig"}). Among the many noteworthy datasets, there are 8 datasets investigating differences between monocytes subsets; classical (CD14++CD16-), intermediate (CD14+CD16+) and non-classical monocytes (CD14-CD16++) ^[@ref-32]--\ [@ref-34]^ \[GXB: [GSE16836](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lv), [GSE18565](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lq), [GSE25913](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lr), [GSE34515](http://monocyte.gxbsidra.org/dm3/miniURL/view/Ls), [GSE35457](http://monocyte.gxbsidra.org/dm3/miniURL/view/M7), [GSE51997](http://monocyte.gxbsidra.org/dm3/geneBrowser/show/4000076), [GSE60601](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lt), [GSE66936](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lu)\]. Another dataset from Banchereau and colleagues investigated responses of monocyte and dendritic cells to 13 different vaccines *in vitro* ^[@ref-67]^ \[GXB: [GSE44721](http://monocyte.gxbsidra.org/dm3/miniURL/view/MF)\]. The datasets that comprise our collection are listed in [Table 1](#T1){ref-type="table"} and can be browsed interactively in [GXB](http://monocyte.gxbsidra.org/dm3/geneBrowser/list).

![Thematic composition of the dataset collection.\
Word frequencies extracted from text descriptions of the studies loaded into the GXB tool are depicted as a word cloud. The size of the words is proportional to their frequency.](f1000research-5-9108-g0000){#f1}

![Break down of the dataset collection by category.\
The pie chart on the left panel indicates dataset frequencies by disease status. The chart on the right panel indicates the type of studies carried out for the 58 datasets consisting of monocyte obtained exclusively from healthy donors.](f1000research-5-9108-g0001){#f2}

###### List of datasets constituting the collection.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Title                                                                                                                                Platforms    Diseases                       Number\   Experiments   GEO ID                                                                   Ref
                                                                                                                                                                                   of\                                                                                              
                                                                                                                                                                                   samples                                                                                          
  ------------------------------------------------------------------------------------------------------------------------------------ ------------ ------------------------------ --------- ------------- ------------------------------------------------------------------------ ------------
  [Interaction of bone marrow stroma and monocytes: bone marrow stromal](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mq)\            Affymetrix   Healthy                        8         *In vitro*    [GSE10595](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10595)   [@ref-68]
  [cell lines cultured with monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mq)                                                                                                                                                                                            

  [Monocyte gene expression profiling in familial combined hyperlipidemia and](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mr)\      Affymetrix   Familial combined\             9         *In vitro*    [GSE11393](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11393)   [@ref-69]
  [its modification by atorvastatin treatment](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mr)                                                    hyperlipidemia                                                                                                                  

  [Performance comparison of Affymetrix and Illumina microarray technologies](http://monocyte.gxbsidra.org/dm3/miniURL/view/Ms)        Affymetrix   Acute coronary syndrome        10        *Ex vivo*     [GSE11430](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11430)   [@ref-70]

  [Gene expression profiling in pediatric meningococcal sepsis reveals](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mt)\             Affymetrix   Meningococcal sepsis           41        *Ex vivo*     [GSE11755](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11755)   N/A
  [dynamic changes in NK-cell and cytotoxic molecules](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mt)                                                                                                                                                                            

  [Effect of interferon-gamma on macrophage differentiation and response to](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mu)\        Affymetrix   Healthy                        10        *In vitro*    [GSE11864](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11864)   [@ref-71]
  [Toll-like receptor ligands](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mu)                                                                                                                                                                                                    

  [Human monocyte and dendritic Cell Subtype Gene Arrays](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mw)                            Affymetrix   Healthy                        8         *Ex vivo*     [GSE11943](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11943)   [@ref-72]

  [Microarray analysis of human monocytes infected with *Francisella tularensis*](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mx)    Affymetrix   Healthy                        14        *In vitro*    [GSE12108](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12108)   [@ref-73]

  [Human blood monocyte profile in Ventilator-Associated Pneumonia patients](http://monocyte.gxbsidra.org/dm3/miniURL/view/My)         Affymetrix   Pneumonia                      60        *Ex vivo*     [GSE12838](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12838)   N/A

  [Quercetin supplementation and CD14+ monocyte gene expression](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mz)                     Affymetrix   Healthy                        6         *Ex vivo*     [GSE13899](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13899)   [@ref-74]

  [Effects of PMN-Ectosomes on human macrophages](http://monocyte.gxbsidra.org/dm3/miniURL/view/N0)                                    Affymetrix   Healthy                        16        *In vitro*    [GSE14419](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14419)   N/A

  [Homogeneous monocytes and macrophages from hES cells following](http://monocyte.gxbsidra.org/dm3/miniURL/view/N1)\                  Affymetrix   Healthy                        9         *Ex vivo*     [GSE15791](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15791)   [@ref-75]
  [coculture-free differentiation in M-CSF and IL-3](http://monocyte.gxbsidra.org/dm3/miniURL/view/N1)                                                                                                                                                                              

  [Expression data from human macrophages](http://monocyte.gxbsidra.org/dm3/miniURL/view/N2)                                           Affymetrix   Healthy                        38        *In vitro*    [GSE16385](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16385)   [@ref-76]

  [Transcriptional profiling of CD16+ and CD16- peripheral blood monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/N3)\         Affymetrix   Healthy                        8         *Ex vivo*     [GSE16836](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16836)   [@ref-32]
  [from healthy individuals](http://monocyte.gxbsidra.org/dm3/miniURL/view/N3)                                                                                                                                                                                                      

  [COPD-Specific Gene Expression Signatures of Alveolar Macrophages](http://monocyte.gxbsidra.org/dm3/miniURL/view/N4)\                Affymetrix   Chronic Obstructive\           12        *Ex vivo*     [GSE16972](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16972)   [@ref-77]
  [as well as Peripheral Blood Monocytes Overlap and Correlate with Lung](http://monocyte.gxbsidra.org/dm3/miniURL/view/N4)\                        Pulmonary Disease                                                                                                               
  [Function](http://monocyte.gxbsidra.org/dm3/miniURL/view/N4)                                                                                                                                                                                                                      

  [Loss-of-function mutations in REP-1 affect intracellular vesicle transport in](http://monocyte.gxbsidra.org/dm3/miniURL/view/N5)\   Affymetrix   Choroideremia                  15        *Ex vivo*     [GSE17549](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17549)   [@ref-78]
  [fibroblasts and monocytes of CHM patients](http://monocyte.gxbsidra.org/dm3/miniURL/view/N5)                                                                                                                                                                                     

  [Effect of two weeks erythropoietin treatment on monocyte transcriptomes of](http://monocyte.gxbsidra.org/dm3/miniURL/view/N6)\      Illumina     Cardiorenal syndrome           48        *Ex vivo*     [GSE17582](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17582)   N/A
  [cardiorenal patients](http://monocyte.gxbsidra.org/dm3/miniURL/view/N6)                                                                                                                                                                                                          

  [Comparison of gene expression profiles between human monocyte subsets](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lq)            Affymetrix   Healthy                        6         *Ex vivo*     [GSE18565](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18565)   [@ref-79]

  [Subpopulations of CD163 positive macrophages are classically activated in](http://monocyte.gxbsidra.org/dm3/miniURL/view/N7)\       Illumina     Psoriasis                      58        *Ex vivo*     [GSE18686](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18686)   [@ref-80]
  [psoriasis](http://monocyte.gxbsidra.org/dm3/miniURL/view/N7)                                                                                                                                                                                                                     

  [Mycobacterium tuberculosis Chaperonin 60.1 has Bipolar Effects on Human](http://monocyte.gxbsidra.org/dm3/miniURL/view/N8)\         Affymetrix   Healthy                        21        *In vitro*    [GSE18794](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18794)   N/A
  [peripheral blood-derived Monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/N8)                                                                                                                                                                                            

  [Blood Transcriptional Profiles of Active TB (Separated cell)](http://monocyte.gxbsidra.org/dm3/miniURL/view/N9)                     Illumina     Tuberculosis                   44        *Ex vivo*     [GSE19443](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19443)   [@ref-11]

  [Filaria induced monocyte dysfunction and its reversal following treatment](http://monocyte.gxbsidra.org/dm3/miniURL/view/NA)        Affymetrix   Filariasis                     14        *Ex vivo*     [GSE2135](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE2135)     [@ref-81]

  [Ubiquinol-induced gene expression signatures are translated into reduced](http://monocyte.gxbsidra.org/dm3/miniURL/view/NB)\        Affymetrix   Healthy                        6         *Ex vivo*     [GSE21351](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21351)   [@ref-82]
  [erythropoiesis and LDL cholesterol levels in humans](http://monocyte.gxbsidra.org/dm3/miniURL/view/NB)                                                                                                                                                                           

  [Monocyte vs Macrophage Study](http://monocyte.gxbsidra.org/dm3/miniURL/view/NC)                                                     Affymetrix   Healthy                        6         *In vitro*    [GSE22373](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22373)   [@ref-83]

  [Monocyte gene expression patterns distinguish subjects with and without](http://monocyte.gxbsidra.org/dm3/miniURL/view/ND)\         Illumina     Carotid atherosclerosis        95        *Ex vivo*     [GSE23746](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23746)   N/A
  [atherosclerosis](http://monocyte.gxbsidra.org/dm3/miniURL/view/ND)                                                                                                                                                                                                               

  [Deconvoluting Early Post-Transplant Immunity Using Purified Cell Subsets](http://monocyte.gxbsidra.org/dm3/miniURL/view/NE)\        Affymetrix   Kidney Transplantation         179       *Ex vivo*     [GSE24223](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24223)   [@ref-84]
  [Reveals Functional Networks Not Evident by Whole Blood Analysis](http://monocyte.gxbsidra.org/dm3/miniURL/view/NE)                                                                                                                                                               

  [Cooperative and redundant signaling of leukotriene B4 and leukotriene D4](http://monocyte.gxbsidra.org/dm3/miniURL/view/NG)\        Affymetrix   Healthy                        10        *In vitro*    [GSE24869](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24869)   [@ref-85]
  [in human monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/NG)                                                                                                                                                                                                            

  [Gene expression profiling of the classical (CD14++CD16-), intermediate](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lr)\          Illumina     Healthy                        24        *Ex vivo*     [GSE25913](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25913)   [@ref-34]
  [(CD14++CD16+) and nonclassical (CD14+CD16+) human monocyte](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lr)\                                                                                                                                                                   
  [subsets](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lr)                                                                                                                                                                                                                       

  [Direct Cell Conversion of Human Fibroblasts to Monocytic phagocytes by](http://monocyte.gxbsidra.org/dm3/miniURL/view/NH)\          Illumina     Dermatomyositis                15        *Ex vivo*     [GSE27304](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27304)   N/A
  [Forced Expression of Monocytic Regulatory Network Elements](http://monocyte.gxbsidra.org/dm3/miniURL/view/NH)                                                                                                                                                                    

  [cMyb and vMyb in human monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/NI)                                                 Affymetrix   Healthy                        6         *In vitro*    [GSE2816](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE2816)     [@ref-86]

  [Temporal transcriptional changes in human monocytes following acute](http://monocyte.gxbsidra.org/dm3/miniURL/view/NJ)\             Illumina     Acute myocardial infarction    76        *Ex vivo*     [GSE28454](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28454)   N/A
  [myocardial infarction: The GerMIFs monocyte expression study](http://monocyte.gxbsidra.org/dm3/miniURL/view/NJ)                                                                                                                                                                  

  [mRNA expression profiling of human immune cell subset (Roche)](http://monocyte.gxbsidra.org/dm3/miniURL/view/NK)                    Affymetrix   Healthy                        47        *Ex vivo*     [GSE28490](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28490)   [@ref-87]

  [mRNA expression profiling of human immune cell subsets (HUG)](http://monocyte.gxbsidra.org/dm3/miniURL/view/NL)                     Affymetrix   Healthy                        33        *Ex vivo*     [GSE28491](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28491)   [@ref-87]

  [Changes in gene expression profiles in patients with 5q- syndrome in](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lw)\            Illumina     5q- syndrome                   17        *Ex vivo*     [GSE31460](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31460)   N/A
  [CD14+ monocytes caused by lenalidomide treatment](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lw)                                                                                                                                                                              

  [Genome-wide analysis of lupus immune complex stimulation of purified](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lx)\            Illumina     Healthy                        8         *In vitro*    [GSE32278](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32278)   [@ref-88]
  [CD14+ monocytes and how this response is regulated by C1q](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lx)                                                                                                                                                                     

  [Transcriptome analysis of circulating monocytes in obese patients before](http://monocyte.gxbsidra.org/dm3/miniURL/view/Ly)\        Illumina     Obesity                        48        *Ex vivo*     [GSE32575](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32575)   [@ref-89]
  [and three months after bariatric surgery](http://monocyte.gxbsidra.org/dm3/miniURL/view/Ly)                                                                                                                                                                                      

  [CD4 on human monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lz)                                                           Affymetrix   Healthy                        6         *In vitro*    [GSE32939](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32939)   [@ref-90]

  [Peripheral Blood Monocyte Gene Expression in Recent-Onset Type 1](http://monocyte.gxbsidra.org/dm3/miniURL/view/M0)\                Illumina     Type 1 Diabetes                22        *Ex vivo*     [GSE33440](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE33440)   [@ref-91]
  [Diabetes](http://monocyte.gxbsidra.org/dm3/miniURL/view/M0)                                                                                                                                                                                                                      

  [Traffic-related Particulate Matter Upregulates Allergic Responses by a](http://monocyte.gxbsidra.org/dm3/miniURL/view/M1)\          Affymetrix   Healthy                        16        *In vitro*    [GSE34025](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34025)   N/A
  [Notch-pathway Dependent Mechanism](http://monocyte.gxbsidra.org/dm3/miniURL/view/M1)                                                                                                                                                                                             

  [Human monocyte activation with NOD2L vs. TLR2/1L](http://monocyte.gxbsidra.org/dm3/miniURL/view/M2)                                 Affymetrix   Healthy                        45        *In vitro*    [GSE34156](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34156)   [@ref-92]

  [Bacillus anthracis\' lethal toxin induces broad transcriptional responses in](http://monocyte.gxbsidra.org/dm3/miniURL/view/M3)\    Affymetrix   Healthy                        8         *In vitro*    [GSE34407](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34407)   [@ref-93]
  [human peripheral monocyte](http://monocyte.gxbsidra.org/dm3/miniURL/view/M3)                                                                                                                                                                                                     

  [Gene expression profiles of human blood classical monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/M4)\                     Affymetrix   Healthy                        9         *Ex vivo*     [GSE34515](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34515)   N/A
  [(CD14++CD16-), CD16 positive monocytes (CD14+16++ and](http://monocyte.gxbsidra.org/dm3/miniURL/view/M4)\                                                                                                                                                                        
  [CD14++CD16+), and CD1c+ CD19- dendritic cells](http://monocyte.gxbsidra.org/dm3/miniURL/view/M4)                                                                                                                                                                                 

  [Genome-wide analysis of monocytes and T cells\' response to interferon](http://monocyte.gxbsidra.org/dm3/miniURL/view/M5)\          Illumina     Healthy                        12        *In vitro*    [GSE34627](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE34627)   [@ref-94]
  [beta](http://monocyte.gxbsidra.org/dm3/miniURL/view/M5)                                                                                                                                                                                                                          

  [Highly pathogenic influenza virus inhibit Inflammatory Responses in](http://monocyte.gxbsidra.org/dm3/miniURL/view/M6)\             Affymetrix   Healthy                        12        *In vitro*    [GSE35283](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35283)   N/A
  [Monocytes via Activation of the Rar-Related Orphan Receptor Alpha](http://monocyte.gxbsidra.org/dm3/miniURL/view/M6)\                                                                                                                                                            
  [(RORalpa)](http://monocyte.gxbsidra.org/dm3/miniURL/view/M6)                                                                                                                                                                                                                     

  [Transcriptome profiles of human monocyte and dendritic cell subsets](http://monocyte.gxbsidra.org/dm3/miniURL/view/M7)              Illumina     Healthy                        49        *Ex vivo*     [GSE35457](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35457)   [@ref-95]

  [Influenza virus A infected monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/M8)                                             Illumina     Healthy                        6         *In vitro*    [GSE35473](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35473)   [@ref-96]

  [PGE2-induced OSM expression](http://monocyte.gxbsidra.org/dm3/miniURL/view/M9)                                                      Affymetrix   Chronic wound                  6         *Ex vivo*     [GSE36995](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36995)   [@ref-97]

  [Inflammatory Expression Profiles in Monocyte to Macrophage Differentiation](http://monocyte.gxbsidra.org/dm3/miniURL/view/MA)\      Illumina     Systemic lupus\                72        *Ex vivo*     [GSE37356](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE37356)   N/A
  [amongst Patients with Systemic Lupus Erythematosus and Healthy Controls](http://monocyte.gxbsidra.org/dm3/miniURL/view/MA)\                      erythematosus                                                                                                                   
  [with and without an Atherosclerosis Phenotype](http://monocyte.gxbsidra.org/dm3/miniURL/view/MA)                                                                                                                                                                                 

  [New insights into key genes and pathways involved in the pathogenesis of](http://monocyte.gxbsidra.org/dm3/miniURL/view/MB)\        Affymetrix   Acute anterior uveitis         6         *In vitro*    [GSE37588](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE37588)   N/A
  [HLA-B27-associated acute anterior uveitis](http://monocyte.gxbsidra.org/dm3/miniURL/view/MB)                                                                                                                                                                                     

  [Analysis of blood myelomonocytic cells from RCC patients](http://monocyte.gxbsidra.org/dm3/miniURL/view/NM)                         Illumina     Renal cell carcinoma           8         *Ex vivo*     [GSE38424](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38424)   [@ref-98]

  [Nanotoxicogenomic study of ZnO and TiO2 responses](http://monocyte.gxbsidra.org/dm3/miniURL/view/MC)                                Illumina     Healthy                        90        *In vitro*    [GSE39316](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39316)   N/A

  [Macrophage Microvesicles Induce Macrophage Differentiation and miR-223](http://monocyte.gxbsidra.org/dm3/miniURL/view/MD)\          Affymetrix   Healthy                        24        *In vitro*    [GSE41889](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41889)   [@ref-99]
  [Transfer](http://monocyte.gxbsidra.org/dm3/miniURL/view/MD)                                                                                                                                                                                                                      

  [TREM-1 is a novel therapeutic target in Psoriasis](http://monocyte.gxbsidra.org/dm3/geneBrowser/show/4000026)                       Affymetrix   Psoriasis                      15        *In vitro*    [GSE42305](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42305)   [@ref-100]

  [Comparison study between Uremic patient with Healthy control](http://monocyte.gxbsidra.org/dm3/geneBrowser/show/4000044)            Affymetrix   Chronic kidney disease         6         *Ex vivo*     [GSE43484](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43484)   N/A

  [Microarray analysis of IL-10 stimulated adherent peripheral blood](http://monocyte.gxbsidra.org/dm3/miniURL/view/ME)\               Affymetrix   Healthy                        8         *In vitro*    [GSE43700](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43700)   [@ref-101]
  [mononuclear cells](http://monocyte.gxbsidra.org/dm3/miniURL/view/ME)                                                                                                                                                                                                             

  [Monocytes and Dendritic cells stimulated by 13 human vaccines and LPS](http://monocyte.gxbsidra.org/dm3/miniURL/view/MF)            Illumina     Vaccination                    128       *In vitro*    [GSE44721](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE44721)   [@ref-67]

  [Gene expression profile of human monocytes stimulated with all-trans](http://monocyte.gxbsidra.org/dm3/miniURL/view/MG)\            Affymetrix   Healthy                        12        *In vitro*    [GSE46268](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46268)   [@ref-102]
  [retinoic acid (ATRA) or 1,25a-dihydroxyvitamin D3 (1,25D3)](http://monocyte.gxbsidra.org/dm3/miniURL/view/MG)                                                                                                                                                                    

  [Transcriptome analysis of blood monocytes from sepsis patients](http://monocyte.gxbsidra.org/dm3/miniURL/view/MI)                   Illumina     Sepsis                         44        *Ex vivo*     [GSE46955](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46955)   [@ref-103]

  [Tumor-educated circulating monocytes are powerful specific biomarkers for](http://monocyte.gxbsidra.org/dm3/miniURL/view/MH)\       Illumina     Colorectal Cancer              93        *Ex vivo*     [GSE47756](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47756)   [@ref-49]
  [diagnosis of colorectal cancer](http://monocyte.gxbsidra.org/dm3/miniURL/view/MH)                                                                                                                                                                                                

  [Similarities and differences between macrophage polarized gene profiles](http://monocyte.gxbsidra.org/dm3/miniURL/view/MJ)          Illumina     Healthy                        12        *In vitro*    [GSE49240](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49240)   [@ref-104]

  [The effect of cell subset isolation method on gene expression in leukocytes.](http://monocyte.gxbsidra.org/dm3/miniURL/view/MK)     Illumina     Healthy                        50        *Ex vivo*     [GSE50008](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50008)   N/A

  [Transcriptome analysis of HIV-infected peripheral blood monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/ML)                Illumina     HIV                            86        *Ex vivo*     [GSE50011](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE50011)   [@ref-105]

  [Gene expression profiles in T-lymphocytes and Monocytes of participants of](http://monocyte.gxbsidra.org/dm3/miniURL/view/MM)\      Affymetrix   Healthy                        66        *Ex vivo*     [GSE5105](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5105)     N/A
  [the Tour de France 2005](http://monocyte.gxbsidra.org/dm3/miniURL/view/MM)                                                                                                                                                                                                       

  [Effects of exercise on gene expression level in human monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/MN)                  Affymetrix   Healthy                        24        *Ex vivo*     [GSE51835](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51835)   [@ref-106]

  [T helper lymphocyte- and monocyte-specific type I interferon (IFN)](http://monocyte.gxbsidra.org/dm3/miniURL/view/MO)\              Affymetrix   Autoimmune diseases            36        *Ex vivo*     [GSE51997](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51997)   [@ref-107]
  [signatures in autoimmunity and viral infection.](http://monocyte.gxbsidra.org/dm3/miniURL/view/MO)                                                                                                                                                                               

  [Longitudinal comparison of monocytes from an HIV viremic vs avirmeic](http://monocyte.gxbsidra.org/dm3/miniURL/view/MP)\            Affymetrix   HIV                            16        *Ex vivo*     [GSE5220](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5220)     [@ref-108]
  [state](http://monocyte.gxbsidra.org/dm3/miniURL/view/MP)                                                                                                                                                                                                                         

  [Expression data from monocytes and monocyte derived macrophages](http://monocyte.gxbsidra.org/dm3/miniURL/view/MQ)                  Affymetrix   Healthy                        12        *In vitro*    [GSE52647](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52647)   N/A

  [Transcriptome analysis of primary monocytes from HIV+ patients with](http://monocyte.gxbsidra.org/dm3/miniURL/view/MR)\             Illumina     HIV                            14        *Ex vivo*     [GSE52900](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52900)   [@ref-109]
  [differential responses to therapy](http://monocyte.gxbsidra.org/dm3/miniURL/view/MR)                                                                                                                                                                                             

  [Human blood monocyte response to IL-17A in culture](http://monocyte.gxbsidra.org/dm3/miniURL/view/MS)                               Affymetrix   Healthy                        6         *In vitro*    [GSE54884](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54884)   N/A

  [Divergent genome wide transcriptional profiles from immune cell subsets](http://monocyte.gxbsidra.org/dm3/miniURL/view/MT)\         Illumina     Systemic lupus\                208       *Ex vivo*     [GSE55447](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55447)   [@ref-110]
  [isolated from SLE patients with different ancestral backgrounds](http://monocyte.gxbsidra.org/dm3/miniURL/view/MT)                               erythematosus                                                                                                                   

  [Cell Specific Expression & Pathway Analyses Reveal Novel Alterations in](http://monocyte.gxbsidra.org/dm3/miniURL/view/MU)\         Affymetrix   Trauma patients                42        *Ex vivo*     [GSE5580](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5580)     [@ref-111]
  [Trauma-Related Human T-Cell & Monocyte Pathways](http://monocyte.gxbsidra.org/dm3/miniURL/view/MU)                                                                                                                                                                               

  [Immune Variation Project (ImmVar) \[CD14\]](http://monocyte.gxbsidra.org/dm3/miniURL/view/MV)                                       Affymetrix   Healthy                        485       *Ex vivo*     [GSE56034](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56034)   N/A

  [Transcriptomics of human monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/MW)                                               Illumina     Healthy                        1202      *Ex vivo*     [GSE56045](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56045)   [@ref-112]

  [Effect of vitamin D treatment on human monocyte](http://monocyte.gxbsidra.org/dm3/miniURL/view/MX)                                  Affymetrix   Healthy                        16        *In vitro*    [GSE56490](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56490)   NA

  [Monocytes of patients with familial hypercholesterolemia show alterations in](http://monocyte.gxbsidra.org/dm3/miniURL/view/MY)\    Affymetrix   Hypercholesterolemia           23        *Ex vivo*     [GSE6054](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6054)     [@ref-113]
  [cholesterol metabolism](http://monocyte.gxbsidra.org/dm3/miniURL/view/MY)                                                                                                                                                                                                        

  [Gene expression data from CD14++ CD16- classical monocytes from](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lt)\                 Affymetrix   Pancreatic ductal\             12        *Ex vivo*     [GSE60601](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60601)   N/A
  [healthy volunteers and patients with pancreatic ductal adenocarcinoma](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lt)                         adenocarcinoma                                                                                                                  

  [Activation of the JAK/STAT pathway in Behcet\'s Disease](http://monocyte.gxbsidra.org/dm3/miniURL/view/MZ)                          Affymetrix   Behcet's Disease               29        *Ex vivo*     [GSE61399](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61399)   N/A

  [Alarmins MRP8 and MRP14 induce stress-tolerance in phagocytes under](http://monocyte.gxbsidra.org/dm3/miniURL/view/Ma)\             Illumina     Sterile Inflammation           12        *In vitro*    [GSE61477](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61477)   N/A
  [sterile inflammatory conditions](http://monocyte.gxbsidra.org/dm3/miniURL/view/Ma)                                                                                                                                                                                               

  [GM-CSF induced gene-regulation in human monocytes](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mb)                                Affymetrix   Healthy                        6         *In vitro*    [GSE63662](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63662)   [@ref-114]

  [Treatment of human monocytes with TLR7 or TLR8 agonists](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mc)                          Affymetrix   Healthy                        9         *In vitro*    [GSE64480](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64480)   [@ref-115]

  [Restricted Dendritic Cell and Monocyte Progenitors in Human Cord Blood](http://monocyte.gxbsidra.org/dm3/miniURL/view/Md)\          Illumina     Healthy                        36        *Ex vivo*     [GSE65128](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65128)   [@ref-116]
  [and Bone Marrow](http://monocyte.gxbsidra.org/dm3/miniURL/view/Md)                                                                                                                                                                                                               

  [Interleukin-1- and Type I Interferon-Dependent Enhanced Immunogenicity](http://monocyte.gxbsidra.org/dm3/miniURL/view/Me)\          Illumina     Vaccination                    20        *In vitro*    [GSE65412](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65412)   NA
  [of an NYVAC-HIV-1 Env-Gag-Pol-Nef Vaccine Vector with Dual Deletions of](http://monocyte.gxbsidra.org/dm3/miniURL/view/Me)\                                                                                                                                                      
  [Type I and Type II Interferon-Binding Proteins](http://monocyte.gxbsidra.org/dm3/miniURL/view/Me)                                                                                                                                                                                

  [Comparative analysis of monocytes from healthy donors, patients with](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mf)\            Illumina     Breast cancer and Bacterial\   13        *Ex vivo*     [GSE65517](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65517)   [@ref-50]
  [metastatic breast cancer, sepsis or tuberculosis.](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mf)                                             infection                                                                                                                       

  [Expression data from intermediate monocytes from healthy donors and](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lu)\             Affymetrix   Autoimmune uveitis             21        *Ex vivo*     [GSE66936](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66936)   [@ref-39]
  [autoimmune uveitis patients](http://monocyte.gxbsidra.org/dm3/miniURL/view/Lu)                                                                                                                                                                                                   

  [Induction of Dendritic Cell-like Phenotype in Macrophages during Foam Cell](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mg)\      Affymetrix   Healthy                        22        *In vitro*    [GSE7138](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7138)     [@ref-117]
  [Formation](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mg)                                                                                                                                                                                                                     

  [Genome Wide Gene Expression Study of Circulating Monocytes in human](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mh)\             Affymetrix   Healthy                        26        *Ex vivo*     [GSE7158](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7158)     N/A
  [with extremely high vs. low bone mass](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mh)                                                                                                                                                                                         

  [Genomic profiles for human peripheral blood T cells, B cells, natural killer](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mi)\    Affymetrix   Healthy                        18        *Ex vivo*     [GSE72642](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72642)   [@ref-118]
  [cells, monocytes, and polymorphonuclear cells: comparisons to ischemic](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mi)\                                                                                                                                                       
  [stroke, migraine, and Tourette syndrome](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mi)                                                                                                                                                                                       

  [Expression data from monocytes of individuals with different collateral flow](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mj)\    Affymetrix   Coronary artery disease        160       *Ex vivo*     [GSE7638](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7638)     [@ref-39]
  [index CFI](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mj)                                                                                                                                                                                                                     

  [Leukotriene D4 induces gene expression in human monocytes through](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mk)\               Affymetrix   Healthy                        8         *In vitro*    [GSE7807](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7807)     [@ref-119]
  [cysteinyl leukotriene type I receptor](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mk)                                                                                                                                                                                         

  [Gene expression profile during monocytes to macrophage differentiation](http://monocyte.gxbsidra.org/dm3/miniURL/view/Ml)           Affymetrix   Healthy                        9         *In vitro*    [GSE8286](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE8286)     N/A

  [Toll-like receptor triggering of a vitamin D-mediated human antimicrobial](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mm)\       Affymetrix   Healthy                        50        *In vitro*    [GSE8921](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE8921)     [@ref-120]
  [response](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mm)                                                                                                                                                                                                                      

  [TRAIL Is a Novel Antiviral Protein against Dengue Virus](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mn)                          Affymetrix   Dengue                         10        *In vitro*    [GSE9378](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE9378)     NA

  [Gene Expression-Based High Throughput Screening: APL Treatment with](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mo)\             Affymetrix   Leukemia                       24        *Ex vivo*     [GSE976](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE976)       [@ref-121]
  [Candidate Compounds](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mo)                                                                                                                                                                                                           

  [Innate immune responses to TREM-1 activation](http://monocyte.gxbsidra.org/dm3/miniURL/view/Mp)                                     Affymetrix   Healthy                        11        *In vitro*    [GSE9988](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE9988)     [@ref-122]
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Dataset upload and annotation on GXB
------------------------------------

Once a final selection was made each dataset was downloaded from GEO in the SOFT file format. It was in turn uploaded on an instance of the Gene Expression Browser (GXB) hosted on the Amazon Web Services cloud. Available sample and study information were also uploaded. Samples were grouped according to possible interpretations of study results and ranking based on the different group comparisons that were computed (e.g. comparing monocyte isolated from case vs controls in studies where profiling was performed *ex-vivo*; or stimulated vs medium control in *in vitro* experiments).

Short Gene Expression Brower tutorial
-------------------------------------

The GXB software has been described in detail in a recent publication ^[@ref-20]^. This custom software interface provides users with a means to easily navigate and filter the dataset collection available at <http://monocyte.gxbsidra.org/dm3/landing.gsp>. A web tutorial is also available online: <http://monocyte.gxbsidra.org/dm3/tutorials.gsp#gxbtut>. Briefly, datasets of interest can be quickly identified either by filtering using criteria from pre-defined lists on the left or by entering a query term in the search box at the top of the dataset navigation page. Clicking on one of the studies listed in the dataset navigation page opens a viewer designed to provide interactive browsing and graphic representations of large-scale data in an interpretable format. This interface is designed to present ranked gene lists and display expression results graphically in a context-rich environment. Selecting a gene from the rank ordered list on the left of the data-viewing interface will display its expression values graphically in the screen's central panel. Directly above the graphical display drop down menus give users the ability: a) To change how the gene list is ranked; this allows the user to change the method used to rank the genes, or to include only genes that are selected for specific biological interest; b) To change sample grouping (Group Set button), in some datasets a user can switch between groups based on cell type to groups based on disease type, for example; c) To sort individual samples within a group based on associated categorical or continuous variables (e.g. gender or age); d) To toggle between the bar chart view and a box plot view, with expression values represented as a single point for each sample. Samples are split into the same groups whether displayed as a bar chart or box plot; e) To provide a color legend for the sample groups; f) To select categorical information that is to be overlaid at the bottom of the graph. For example, the user can display gender or treatment status in this manner; g) To provide a color legend for the categorical information overlaid at the bottom of the graph; and h) To download the graph as a png image or csv file for performing a separate analysis. Measurements have no intrinsic utility in absence of contextual information. It is this contextual information that makes the results of a study or experiment interpretable. It is therefore important to capture, integrate and display information that will give users the ability to interpret data and gain new insights from it. We have organized this information under different tabs directly above the graphical display. The tabs can be hidden to make more room for displaying the data plots, or revealed by clicking on the blue "show info panel" button on the top right corner of the display. Information about the gene selected from the list on the left side of the display is available under the "Gene" tab. Information about the study is available under the "Study" tab. Information available about individual samples is provided under the "Sample" tab. Rolling the mouse cursor over a bar chart\'s element while displaying the "Sample" tab lists any clinical, demographic, or laboratory information available for the selected sample. Finally, the "Downloads" tab allows advanced users to retrieve the original dataset for analysis outside this tool. It also provides all available sample annotation data for use alongside the expression data in third party analysis software. Other functionalities are provided under the "Tools" drop-down menu located in the top right corner of the user interface. Some of the notable functionalities available through this menu include: a) Annotations, which provides access to all the ancillary information about the study, samples and dataset organized across different tabs; b) Cross-project view, which provides the ability for a given gene to browse through all available studies; c) Copy link, which generates a mini-URL encapsulating information about the display settings in use and that can be saved and shared with others (clicking on the envelope icon on the toolbar inserts the url in an email message via the local email client); and d) Chart options, which gives user the option to customize chart labels.

Dataset validation
------------------

Quality control checks were performed with the examination of profiles of relevant biological indicators. Known leukocyte markers were used, such as CD14, which is expressed by monocytes and macrophages; as well as markers that would indicate significant contamination of the sample by other leukocyte populations: such as CD3, a T-cells marker; CD19, a B-cell marker; CD56, an NK cell marker ( [Figure 3](#f3){ref-type="fig"}; The expression of the CD14 marker across all studies can be checked using the cross project functionality of GXB: <http://monocyte.gxbsidra.org/dm3/geneBrowser/crossProject?probeID=201743_at&geneSymbol=CD14&geneID=929>). We have systematically verified that expression of the genes encoding those surface markers was consistent with grouping labels provided by depositors. In addition, expression of the XIST transcripts, in which expression is gender-specific, was also examined to determine its concordance with demographic information provided with the GEO submission (expression of XIST should be high in females and low in males).

![Illustrative example showing the abundance levels of CD14 transcripts across samples in a given study.\
The expression of this gene is indicative of the purity of primary human monocyte preparation; this marker is expected to be high in monocyte preparations and low in other leukocyte populations. In this view of the GXB expression of CD14 can be visualized across projects listed on the left.](f1000research-5-9108-g0002){#f3}

Data availability
=================

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2016 Rinchai D et al.

Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

All datasets included in our curated collection are also available publically via the NCBI GEO website: <http://www.ncbi.nlm.nih.gov/geo/>; and are referenced throughout the manuscript by their GEO accession numbers (e.g. [GSE25913](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25913)). Signal files and sample description files can also be downloaded from the GXB tool under the "downloads" tab.

The authors would like to acknowledge all the investigators who decided to make their datasets publically available by sharing them in GEO.
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We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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**General Comments**

Modern genomics, especially with the emergence of high-throughput next-generation sequencing, is generating data at such a rapid rate that new tools for organizing, visualizing, sharing, and integrating heterogeneous data in the context of scientific information are needed for scientists to efficiently use these published data. The Chaussabel group has recently developed an interactive data browsing and visualization web application, the Gene Expression Browser (GXB), to address this problem.

In this data note, Dr. Rinchai *et al.* report a compendium of ninety-six curated human monocyte transcriptome datasets from GEO spanning a broad range of diseases, cell types, and experiments. These datasets were then uploaded to the Gene Expression Browser for exploratory data analysis and dataset validation. The Gene Expression Browser should prove very useful for investigating large datasets; however, I have several questions and comments regarding the curated data itself:

**Title:**

The novel aspect and apparent emphasis of this data note is using the Gene Expression Browser to more easily explore the curated ninety-six datasets. But the current title emphasizes the key information on fostering the knowledge discovery. Please consider rephrasing it by focusing on the monocyte datasets and web application.

**Introduction:**

As the Gene Expression Browser has been described in detail previously, the emphasis of this data note should be on the curated data. It would be helpful to discuss the motivation for creating this particular compendium of monocyte transcriptome datasets as well as the intended use of the curated data given the breadth and heterogeneity of diseases, cell types, and experiments that it includes.

**Methods:**

1\. Please elaborate more specifically on how the datasets were curated. What were the eligibility criteria for inclusion into the compendium?

2\. The table summarizing the published data can difficult to read due to its landscape orientation. Consider rotating the table from a landscape orientation to a portrait orientation.

3\. In the right pie chart of Figure 2, there are twelve datasets studying primary monocytes; however, datasets classified as *in vitro* stimulation, infection, and monocyte subsets may also contain primary monocytes. Better categorization is needed.

4\. Data validation is critical for verifying that a dataset is acceptable for use.  The authors mention performing dataset validation but do not report the related results or summary of their validation.  On page 9, the process of assessing contamination by other leukocyte populations using surface markers should be done carefully as CD14 ^+^ monocytes do share surface marker CD4.

5\. In Fig. 3, it is unclear whether the orange bar plot is referring to CD4 ^+^ T cells or CD4 ^+^ cells in general. They are different cell types.

We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.
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We thank the reviewers for their valuable feedback and suggestions to improve our manuscript.

**Title: **

*Following the suggestion of the reviewers we changed the title of the manuscript to "A curated compendium of of transcriptome datasets of relevance to human monocyte immunobiology research".*

**Introduction: **

*Thanks for raising this point. We added a long paragraph and new references in the introduction to emphasize the role of monocyte across different diseases and the motivation for creating this compendium of monocyte transcriptome datasets.*

**Methods:**

1\. *We have added information about how datasest were selected for inclusion in the collections in the methods section under the title "Identification of monocyte datasets"... **"*** *Using the search query, the results also returned a number of datasets that did not include profiles of monocytes but instead of "monocyte-derived dendritic cells" or "monocyte-derived macrophages". During our manual screen these were excluded as were studies employing monocytic cell lines. Only studies including primary human monocyte profiles were retained."...*

2\. *We agree with the reviewer that presenting the table using landscape orientation makes it difficult to read. We therefore changed table format from landscape to portrait orientation.*

3\. *Thank you for pointing this out. We changed the label on this figure to read "ex-vivo, no treatment". These include studies where monocytes were isolated from healthy subjects for comparison with other cell types, or evaluation of variation among healthy individuals.*

4\. *Assessing contamination can indeed be difficult, especially using this type of data where cell-level information is lacking. We plan to explore with our bioinformatics collaborators the development of a \"scoring\" approach to better quantify potential contamination but this is not a simple matter to address. At this point we have simply verified for each dataset that expression of markers was consistent with grouping labels provided by depositors. We have added language in the manuscript to clarify this point.*

5\. *Thank you for pointing out this typo on this label. This dataset focuses on genomic profile of human blood both CD4+ and CD8+ T cells, B cells, NK cells monocytes and neutrophil. Figure 3 was corrected accordingly as shown in the new Figure 3. *
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In this short descriptive report the authors put their published Gene Expression Browser tool to work in arranging several thousand transcriptome profiles obtained from public datasets that looked at monocyte immunology. They were able to compare groups of monocytes based on phenotypic attributes and rank gene expression. The authors provide a nice summary of the technique and validation.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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